Migraine and fibromyalgia

Headache

Volumn 51, Issue 2, 2011, Pages 295-299

  Evans, Randolph W ^a   De Tommaso, Marina ^a  

^a NONE

Author keywords

fibromyalgia syndrome; migraine; tension type headache

Indexed keywords

AMITRIPTYLINE; VENLAFAXINE;

ADULT; CASE REPORT; CHRONIC TENSION HEADACHE; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; HUMAN; MEDICAL SPECIALIST; MIGRAINE; MIGRAINE WITHOUT AURA; NEUROLOGIC EXAMINATION; NOTE; PRIMARY HEADACHE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RHEUMATOLOGY;

COMORBIDITY; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; PREVALENCE;

EID: 79551606761     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01835.x     Document Type: Note

References (36)

1. Staud R, Rodriguez ME,. Mechanisms of disease: Pain in fibromyalgia syndrome. Nat Clin Pract Rheumatol. 2006; 2: 90-98. (Pubitemid 43239208)
2. Aaron LA,. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol. 2003; 17: 563-574.
3. Peres MF, Young WB, Kaup AO, Zukerman E, Silberstein SD,. Fibromyalgia is common in patients with transformed migraine. Neurology. 2001; 57: 1326-1328.
4. Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H,. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia. 2005; 26: 451-456.
5. Tietjen GE, Herial NA, Hardgrove J, Utley C, White L,. Migraine comorbidity constellations. Headache. 2007; 47: 876-877.
6. de Tommaso M, Sardaro M, Serpino C, et al. Fibromyalgia comorbidity in primary headaches. Cephalalgia. 2009; 29: 453-464.
7. Le H, Tfelt-Hansen P, Russell MB, et al. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia. 2010 Jun 2 [Epub ahead of print] doi: 10.1177/0333102410373159.
8. Schoenen J,. Tension-type headache and fibromyalgia: What's common, what's different? Neurol Sci. 2004; 25 (Suppl. 3): S157-S159.
9. Marcus DA, Bernstein C, Rudy TE,. Fibromyalgia and headache: An epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol. 2005; 24: 595-601.
10. Hudson JI, Goldenberg DL, Pope HG, Keck PE Jr, Schlesinger L,. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992; 92: 363-367.
11. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990; 33: 160-172.
12. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010; 62: 600-610.
13. Garcia-Larrea L, Convers P, Magnin M, et al. Laser-evoked potential abnormalities in central pain patients: The influence of spontaneous and provoked pain. Brain. 2002; 125: 2766-2781.
14. Gibson SJ, Littlejohn GO, Gorman MM, Helme RD, Granges G,. Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain. 1994; 58: 185-193.
15. Pujol J, Lõpez-Solà M, Ortiz H, et al. Mapping brain response to pain in fibromyalgia patients using temporal analysis of FMRI. Plos ONE. 2009; 4: e5224.
16. de Tommaso M,. Laser-evoked potentials in primary headaches and cranial neuralgias. Expert Rev Neurother. 2008; 8: 1339-1345.
17. Burstein R, Cutrer MF, Yarnitsky D,. The development of cutaneous allodynia during a migraine attack: Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000; 123: 1703-1709.
18. Bendtsen L,. Central sensitization in tension-type headache: Possible pathophysiological mechanisms. Cephalalgia. 2000; 20: 486-508.
19. Hollins M, Harper D, Gallagher S, et al. Perceived intensity and unpleasantness of cutaneous and auditory stimuli: An evaluation of the generalized hypervigilance hypothesis. Pain. 2009; 141: 215-221.
20. Lorenz J,. Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol. 1998; 57: 19-22.
21. Carrillo-de-la-Peña MT, Vallet M, Pérez MI, Gõmez-Perretta C,. Intensity dependence of auditory-evoked cortical potentials in fibromyalgia patients: A test of the generalized hypervigilance hypothesis. J Pain. 2006; 7: 480-487.
22. Ambrosini A, Rossi P, De Pasqua V, Pierelli F, Schoenen J,. Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain. 2003; 126: 2009-2015.
23. de Tommaso M, Federici A, Santostasi R, et al. Laser evoked potentials habituation in fibromyalgia. J Pain. 2011; 12: 116-124.
24. Thompson RF, Spencer WA,. Habituation: A model phe-nomenon for the study of neuronal substrates of behavior. Psychol Rev. 1996; 73: 16-43.
25. Valeriani M, de Tommaso M, Restuccia D, et al. Reduced habituation to experimental pain in migraine patients: A CO2 laser evoked potentials study. Pain. 2003; 105: 57-64.
26. Valeriani M, Sestito A, Le Pera D, et al. Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J. 2005; 26: 975-982. (Pubitemid 40695028)
27. de Tommaso M, Guido M, Sardaro M, et al. Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. Neurosci Lett. 2008; 12: 81-85.
28. Häuser W, Thieme K, Turk DC,. Guidelines on the management of fibromyalgia syndrome-a systematic review. Eur J Pain. 2010; 14: 5-10.
29. Sayar K, Aksu G, Ak I, Tosun M,. Venlafaxine treatment of fibromyalgia. Ann Pharmacother. 2003; 37: 1561-1565.
30. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007; 56: 1336-1344.
31. de Tommaso M, Sardaro M, Vecchio E, Serpino C, Stasi M, Ranieri M,. Central sensitisation phenomena in primary headaches: Overview of a preventive therapeutic approach. CNS Neurol Disord Drug Targets. 2008; 7: 524-535.
32. Leavitt F, Katz RS,. Speed of mental operations in fibromyalgia: A selective naming speed deficit. J Rheumatol. 2008; 35: 1371-1377.
33. Burgmer M, Gaubitz M, Konrad C, et al. Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med. 2009; 71: 566-573.
34. Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ,. Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol. 2008; 35: 1371-1377.
35. Baars MA, van Boxtel MP, Jolles J,. Migraine does not affect cognitive decline: Results from the Maastricht aging study. Headache. 2010; 50: 176-184.
36. Schmitz N, Arkink EB, Mulder M, et al. Frontal lobe structure and executive function in migraine patients. Neurosci Lett. 2008; 440: 92-96.